TELA Bio, Inc.TELANASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+9.7%
5Y CAGR+19.0%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+9.7%/yr
vs +30.3%/yr prior
5Y CAGR
+19.0%/yr
Recent deceleration
Acceleration
-20.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$87.27M+8.3%
2024$80.60M-4.3%
2023$84.19M+27.5%
2022$66.05M+36.9%
2021$48.26M+32.2%
2020$36.51M+28.4%
2019$28.43M+24.3%
2018$22.88M+17.6%
2017$19.46M-